Thalys Medical Technology Group

Thalys Medical Technology Group Net Margin

The Net Profit Margin of Thalys Medical Technology Group (603716.SS) as of Oct 29, 2026 is -19.25 %. In the previous year, Net Profit Margin was -11.56 % — a change of 66.56% (lower).

Net Margin

-19.25 %

YoY

66.56%

Last updated:

Net Profit Margin of Thalys Medical Technology Group is 2025 -19.25 % . Net Profit Margin of Thalys Medical Technology Group was 2024 -11.56 % . It decreases by 66.56% lower compared to the previous year.

Thalys Medical Technology Group's net margin stands at -19.2%, down from -1.9% several years earlier.

The Thalys Medical Technology Group Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
7.15 CNY
Jan 1, 2019
6.03 CNY
Jan 1, 2020
2.71 CNY
Jan 1, 2021
-1.90 CNY
Jan 1, 2022
-6.66 CNY
Jan 1, 2023
-7.90 CNY
Jan 1, 2024
-11.56 CNY
Jan 1, 2025
-19.25 CNY
The Thalys Medical Technology Group Net Margin history
YEARNet MarginYoY
-19.25 %+66.56%
-11.56 %+46.20%
-7.90 %+18.70%
-6.66 %+249.66%
-1.90 %-170.32%
2.71 %-55.10%
6.03 %-15.61%
7.15 %-29.90%
10.20 %-7.20%
10.99 %-5.32%
11.60 %-8.63%
12.70 %+10,050.85%
0.13 %-7.58%
0.14 %-30.59%
0.20 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Thalys Medical Technology Group Stock analysis

What does Thalys Medical Technology Group do? Thalys Medical Technology Group Corp, based in Wuhan, China, operates in the Health Care sector with a focus on Biotechnology. The company develops, produces, and sells in vitro diagnostic products, including reagents, consumables, and equipment. It serves major domestic markets such as Hubei, Hunan, Jiangsu, Henan, and Shanghai, employing 1,474 full-time staff. Listed on October 31, 2016, Thalys specializes in diagnostic solutions for the Chinese healthcare market. Thalys Medical Technology Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Thalys Medical Technology Group stock

Net Profit Margin of Thalys Medical Technology Group is -19.25 % in 2025.

Net Profit Margin of Thalys Medical Technology Group changed from -11.56 % to -19.25 %, representing a 66.56% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Thalys Medical Technology Group since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Thalys Medical Technology Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Thalys Medical Technology Group

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Thalys Medical Technology Group